We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
-$17.8M
Cap. Flow
+$2.5M
Cap. Flow %
0.14%
Top 10 Hldgs %
14.6%
Holding
323
New
23
Increased
120
Reduced
120
Closed
29

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$19.6M
2
HCSG icon
Healthcare Services Group
HCSG
+$16.1M
3
SLAB icon
Silicon Laboratories
SLAB
+$15.7M
4
PRLB icon
Protolabs
PRLB
+$9.88M
5
DECK icon
Deckers Outdoor
DECK
+$9.57M

Sector Composition

Rank Sector Weight
1 Industrials 21.59%
2 Technology 19.03%
3 Healthcare 16.92%
4 Consumer Discretionary 12.43%
5 Financials 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APOG icon
176
Apogee Enterprises
APOG
$908M
$1.93M 0.11%
43,925
+200
+0.5% +$7.93K
VCRA
177
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.93M 0.11%
+151,254
New +$2.09M
CAH icon
178
Cardinal Health
CAH
$55.4B
$1.91M 0.11%
23,358
+4,796
+26% +$390K
AERI
179
DELISTED
Aerie Pharmaceuticals
AERI
$1.91M 0.11%
157,023
+2,790
+2% +$44.1K
SAIA icon
180
Saia
SAIA
$9.72B
$1.9M 0.11%
67,569
+800
+1% +$19.7K
KITE
181
DELISTED
Kite Pharma, Inc.
KITE
$1.86M 0.11%
40,421
+876
+2% +$42.4K
DOV icon
182
Dover
DOV
$28.4B
$1.84M 0.11%
35,455
-556
-2% -$27K
EW icon
183
Edwards Lifesciences
EW
$51.7B
$1.84M 0.11%
62,658
-6,111
-9% -$169K
GCO icon
184
Genesco
GCO
$422M
$1.83M 0.11%
25,319
-761
-3% -$49.1K
STBZ
185
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.8M 0.1%
90,981
-100
-0.1% -$1.94K
CIR
186
DELISTED
CIRCOR International, Inc
CIR
$1.79M 0.1%
38,686
+100
+0.3% +$3.88K
SRDX
187
DELISTED
Surmodics
SRDX
$1.78M 0.1%
96,918
-12,014
-11% -$226K
NVGS icon
188
Navigator Holdings
NVGS
$1.28B
$1.78M 0.1%
110,427
+1,800
+2% +$26.2K
CLVS
189
DELISTED
Clovis Oncology, Inc.
CLVS
$1.78M 0.1%
92,878
+3,855
+4% +$81.6K
CHEF icon
190
Chefs' Warehouse
CHEF
$4.5B
$1.78M 0.1%
87,770
+200
+0.2% +$3.29K
RLYP
191
DELISTED
RELYPSA INC COM
RLYP
$1.78M 0.1%
131,174
+3,940
+3% +$67K
ACHC icon
192
Acadia Healthcare
ACHC
$2.94B
$1.77M 0.1%
+32,162
New +$1.84M
MD icon
193
Pediatrix Medical
MD
$2.2B
$1.77M 0.1%
27,327
-312
-1% -$20.7K
CALX icon
194
Calix
CALX
$2.39B
$1.76M 0.1%
248,379
+1,200
+0.5% +$8.48K
STRL icon
195
Sterling Infrastructure
STRL
$16.7B
$1.76M 0.1%
341,731
+1,200
+0.4% +$6.04K
BFX
196
DELISTED
BowFlex Inc.
BFX
$1.72M 0.1%
+89,053
New +$1.67M
CBRE icon
197
CBRE Group
CBRE
$42.9B
$1.71M 0.1%
59,279
-592
-1% -$16.3K
FDS icon
198
Factset
FDS
$10.2B
$1.68M 0.1%
11,090
-109
-1% -$16.3K
KEX icon
199
Kirby Corp
KEX
$6.93B
$1.67M 0.1%
27,701
+2,125
+8% +$116K
CMA
200
DELISTED
Comerica
CMA
$1.67M 0.1%
43,964
+3,437
+8% +$124K

Similar funds

Rice Hall James & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Rice Hall James & Associates held 323 positions worth $1.73B, down 1% from $1.75B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q1 2016 filing shows 23 new, 120 increased, 120 reduced and 29 closed positions. Its largest new stake was Nice: 327,313 shares worth $21.2M. The largest sale was Cinemark Holdings, an estimated $20.5M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

  • Rice Hall James & Associates's largest Q1 2016 buy was Nice: 327,313 shares worth $21.2M.
  • Rice Hall James & Associates added most to Electronics for Imaging in Q1 2016, an estimated $9.25M increase.
  • Rice Hall James & Associates's biggest Q1 2016 reduction was E.W. Scripps, cutting an estimated $9.46M.
  • Rice Hall James & Associates fully exited Cinemark Holdings in Q1 2016, selling an estimated $20.5M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.73B portfolio in Q1 2016.
  • Rice Hall James & Associates opened 23 new positions and closed 29 in Q1 2016.
  • Rice Hall James & Associates's portfolio value fell 1% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q1 2016, filed 26 Apr 2016.